Two Biopharma stocks that need to be considered outside Moderna
00:00 Spokesman a Moderna shares that it is moving to the head today, the FDA provides the company’s limited approval for its lower dose of Covid-19. This comes as a pharmaceutical industry is under pressure, facing a destroyed relationship with HHS Head RFK JR, as well as more risks of tariff policy. Our next guest … Read more